NIHR global group: reducing childhood mortality through prevention of preterm birth mortality and morbidity and stillbirth.

  Our NIHR global health research group will develop and implement clinical strategies to reduce preterm birth and stillbirth related morbidity and mortality, and provide a platform for future clinical trials on preterm birth. Our multidisciplinary team, comprises clinicians and researchers from Malawi, Zambia and the UK with experience in preterm birth/stillbirth and related epidemiological analysis, in high and low and middle income settings AND clinicians, researchers and policy makers and academic training staff from Malawi and Zambia with an interest in preterm birth and stillbirth. It builds on a UK team (Norman, Stock, Norrie) with a very strong track record in design and conduct of clinical trials in preterm birth and stillbirth (STOPPIT [Lancet 2009], OPPTIMUM [Lancet 2015] and ongoing trials AFFIRM, QUIDs, STOPPIT 2), the majority of which have been funded by NIHR

  • Start Date:

    1 April 2018

  • End Date:

    31 March 2021

  • Activity Type:

    Externally Funded Research

  • Funder:

    National Institute for Health Research

  • Value:

    £20564

Project Team